{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:02:29Z","timestamp":1793325749286,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":103,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811388705","type":"print"},{"value":"9789811388712","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-8871-2_5","type":"book-chapter","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T03:02:58Z","timestamp":1565319778000},"page":"81-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Polycystic Kidney Disease and Renal Fibrosis"],"prefix":"10.1007","author":[{"given":"Cheng","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Lin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ki.2011.217","volume":"80","author":"HJ Anders","year":"2011","unstructured":"Anders HJ, Ryu M (2011) Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 80:915\u2013925","journal-title":"Kidney Int"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","volume":"109","author":"KP Anil Kumar Bhunia","year":"2002","unstructured":"Anil Kumar Bhunia KP, Boletta Alessandra, Liu Lijuan, Qian Feng, Pei-Ning Xu et al (2002) PKD1 induces p21waf1 and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 109:157\u2013168","journal-title":"Cell"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1559-0275-9-13","volume":"9","author":"M Bakun","year":"2012","unstructured":"Bakun M, Niemczyk M, Domanski D, Jazwiec R, Perzanowska A et al (2012) Urine proteome of autosomal dominant polycystic kidney disease patients. Clin Proteomics 9:13","journal-title":"Clin Proteomics"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbrc.2006.09.042","volume":"350","author":"M Banzi","year":"2006","unstructured":"Banzi M, Aguiari G, Trimi V, Mangolini A, Pinton P et al (2006) Polycystin-1 promotes PKCalpha-mediated NF-kappaB activation in kidney cells. Biochem Biophys Res Commun 350:257\u2013262","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1681\/ASN.2008040435","volume":"20","author":"AP Bastos","year":"2009","unstructured":"Bastos AP, Piontek K, Silva AM, Martini D, Menezes LF et al (2009) Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia\/reperfusion. J Am Soc Nephrol 20:2389\u20132402","journal-title":"J Am Soc Nephrol"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fped.2017.00221","volume":"5","author":"C Bergmann","year":"2017","unstructured":"Bergmann C (2017) Genetics of autosomal recessive polycystic kidney disease and its differential diagnoses. Front Pediatr 5:221","journal-title":"Front Pediatr"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2353\/ajpath.2007.060455","volume":"170","author":"WM Bernhardt","year":"2007","unstructured":"Bernhardt WM, Wiesener MS, Weidemann A, Schmitt R, Weichert W et al (2007) Involvement of hypoxia-inducible transcription factors in polycystic kidney disease. Am J Pathol 170:830\u2013842","journal-title":"Am J Pathol"},{"key":"5_CR8","doi-asserted-by":"crossref","unstructured":"Cassini MF, Kakade VR, Kurtz E, Sulkowski P, Glazer P et al (2018) Mcp1 promotes macrophage-dependent cyst expansion in autosomal dominant polycystic kidney disease. J Am Soc Nephrol","DOI":"10.1681\/ASN.2018050518"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"F905","DOI":"10.1152\/ajprenal.00421.2006","volume":"292","author":"JM Catania","year":"2007","unstructured":"Catania JM, Chen G, Parrish AR (2007) Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 292:F905\u2013F911","journal-title":"Am J Physiol Renal Physiol"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1172\/JCI21753","volume":"114","author":"V Chauvet","year":"2004","unstructured":"Chauvet V, Tian X, Husson H, Grimm DH, Wang T et al (2004) Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J Clin Invest 114:1433\u20131443","journal-title":"J Clin Invest"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1756-0500-1-131","volume":"1","author":"WC Chen","year":"2008","unstructured":"Chen WC, Tzeng YS, Li H (2008) Gene expression in early and progression phases of autosomal dominant polycystic kidney disease. BMC Res Notes 1:131","journal-title":"BMC Res Notes"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ncb1670","volume":"10","author":"KC Corbit","year":"2008","unstructured":"Corbit KC, Shyer AE, Dowdle WE, Gaulden J, Singla V et al (2008) Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms. Nat Cell Biol 10:70\u201376","journal-title":"Nat Cell Biol"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1046\/j.1523-1755.2001.00065.x","volume":"60","author":"BD Cowley Jr","year":"2001","unstructured":"Cowley BD Jr, Ricardo SD, Nagao S, Diamond JR (2001) Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney Int 60:2087\u20132096","journal-title":"Kidney Int"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/CS20100113","volume":"119","author":"B Dai","year":"2010","unstructured":"Dai B, Liu Y, Mei C, Fu L, Xiong X et al (2010) Rosiglitazone attenuates development of polycystic kidney disease and prolongs survival in Han: SPRD rats. Clin Sci (Lond) 119:323\u2013333","journal-title":"Clin Sci (Lond)"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"e89835","DOI":"10.1371\/journal.pone.0089835","volume":"9","author":"Y Dang","year":"2014","unstructured":"Dang Y, Liu B, Xu P, Zhu P, Zhai Y et al (2014) Gpr48 deficiency induces polycystic kidney lesions and renal fibrosis in mice by activating Wnt signal pathway. PLoS ONE 9:e89835","journal-title":"PLoS ONE"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1046\/j.1523-1755.2001.00963.x","volume":"60","author":"KM Dell","year":"2001","unstructured":"Dell KM, Nemo R, Sweeney WE Jr, Levin JI, Frost P et al (2001) A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease. Kidney Int 60:1240\u20131248","journal-title":"Kidney Int"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1083\/jcb.122.1.103","volume":"122","author":"A Desmouliere","year":"1993","unstructured":"Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103\u2013111","journal-title":"J Cell Biol"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"C487","DOI":"10.1152\/ajpcell.1995.269.2.C487","volume":"269","author":"J Du","year":"1995","unstructured":"Du J, Wilson PD (1995) Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 269:C487\u2013C495","journal-title":"Am J Physiol"},{"key":"5_CR19","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1681\/ASN.V7122495","volume":"7","author":"AA Eddy","year":"1996","unstructured":"Eddy AA (1996) Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495\u20132508","journal-title":"J Am Soc Nephrol"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1160\/TH08-12-0779","volume":"101","author":"AA Eddy","year":"2009","unstructured":"Eddy AA (2009) Serine proteases, inhibitors and receptors in renal fibrosis. Thromb Haemost 101:656\u2013664","journal-title":"Thromb Haemost"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0301-472X(02)00904-9","volume":"30","author":"A Ehrhardt","year":"2002","unstructured":"Ehrhardt A, Ehrhardt GR, Guo X, Schrader JW (2002) Ras and relatives\u2013job sharing and networking keep an old family together. Exp Hematol 30:1089\u20131106","journal-title":"Exp Hematol"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.yexcr.2012.03.021","volume":"318","author":"D Elberg","year":"2012","unstructured":"Elberg D, Jayaraman S, Turman MA, Elberg G (2012) Transforming growth factor-beta inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells. Exp Cell Res 318:1508\u20131516","journal-title":"Exp Cell Res"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1016\/j.yexcr.2010.04.033","volume":"316","author":"L Follonier Castella","year":"2010","unstructured":"Follonier Castella L, Gabbiani G, McCulloch CA, Hinz B (2010) Regulation of myofibroblast activities: calcium pulls some strings behind the scene. Exp Cell Res 316:2390\u20132401","journal-title":"Exp Cell Res"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/35099066","volume":"2","author":"B Geiger","year":"2001","unstructured":"Geiger B, Bershadsky A, Pankov R, Yamada KM (2001) Transmembrane crosstalk between the extracellular matrix\u2013cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2:793\u2013805","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nri1733","volume":"5","author":"S Gordon","year":"2005","unstructured":"Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953\u2013964","journal-title":"Nat Rev Immunol"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham JJ, Mulamalla S, Swenson-Fields KI (2011) Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 7:556\u2013566","journal-title":"Nat Rev Nephrol"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4939-7784-0_6","volume-title":"Polycystic Kidney Disease","author":"James C. Harms","year":"2018","unstructured":"Harms JC, Song CJ, Mrug M (2018) The role of inflammation and fibrosis in cystic kidney disease"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1172\/JCI72272","volume":"124","author":"PC Harris","year":"2014","unstructured":"Harris PC, Torres VE (2014) Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest 124:2315\u20132324","journal-title":"J Clin Invest"},{"key":"5_CR29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2734","volume":"222","author":"S Hassane","year":"2010","unstructured":"Hassane S, Leonhard WN, van der Wal A, Hawinkels LJ, Lantinga-van Leeuwen IS et al (2010) Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease. J Pathol 222:21\u201331","journal-title":"J Pathol"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden MS, Ghosh S (2011) NF-kappaB in immunobiology. Cell Res 21:223\u2013244","journal-title":"Cell Res"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","volume":"26","author":"MS Hayden","year":"2012","unstructured":"Hayden MS, Ghosh S (2012) NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26:203\u2013234","journal-title":"Genes Dev"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.kint.2017.02.017","volume":"92","author":"SJ Holditch","year":"2017","unstructured":"Holditch SJ, Schreiber CA, Harris PC, LaRusso NF, Ramirez-Alvarado M et al (2017) B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease. Kidney Int 92:657\u2013668","journal-title":"Kidney Int"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(94)92344-2","volume":"344","author":"S Horie","year":"1994","unstructured":"Horie S, Higashihara E, Nutahara K, Mikami Y, Okubo A et al (1994) Mediation of renal cyst formation by hepatocyte growth factor. Lancet 344:789\u2013791","journal-title":"Lancet"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1242\/dev.00478","volume":"130","author":"MC Hu","year":"2003","unstructured":"Hu MC, Piscione TD, Rosenblum ND (2003) Elevated SMAD1\/beta-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice. Development 130:2753\u20132766","journal-title":"Development"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00467-013-2726-y","volume":"30","author":"SC Huen","year":"2015","unstructured":"Huen SC, Cantley LG (2015) Macrophage-mediated injury and repair after ischemic kidney injury. Pediatr Nephrol 30:199\u2013209","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"5_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","volume":"368","author":"John J. O'Shea","year":"2013","unstructured":"John J O\u2019Shea, SMH, Louis M Staudt (2013) JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 368:161\u2013170","journal-title":"New England Journal of Medicine"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0002-9440(10)63539-0","volume":"163","author":"D Joly","year":"2003","unstructured":"Joly D, Morel V, Hummel A, Ruello A, Nusbaum P et al (2003) Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration. Am J Pathol 163:1791\u20131800","journal-title":"Am J Pathol"},{"issue":"1","key":"5_CR38","doi-asserted-by":"publisher","first-page":"e24198","DOI":"10.4161\/jkst.24198","volume":"2","author":"MH Kaplan","year":"2013","unstructured":"Kaplan MH (2013) STAT signaling in inflammation. Jak-Stat 2(1):e24198","journal-title":"Jak-Stat"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1681\/ASN.2011010084","volume":"22","author":"A Karihaloo","year":"2011","unstructured":"Karihaloo A, Koraishy F, Huen SC, Lee Y, Merrick D et al (2011) Macrophages promote cyst growth in polycystic kidney disease. J Am Soc Nephrol 22:1809\u20131814","journal-title":"J Am Soc Nephrol"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ki.2009.93","volume":"76","author":"AD Kistler","year":"2009","unstructured":"Kistler AD, Mischak H, Poster D, Dakna M, Wuthrich RP et al (2009) Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int 76:89\u201396","journal-title":"Kidney Int"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"e53016","DOI":"10.1371\/journal.pone.0053016","volume":"8","author":"AD Kistler","year":"2013","unstructured":"Kistler AD, Serra AL, Siwy J, Poster D, Krauer F et al (2013) Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS ONE 8:e53016","journal-title":"PLoS ONE"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4161\/org.4.2.5851","volume":"4","author":"Y Komiya","year":"2008","unstructured":"Komiya Y, Habas R (2008) Wnt signal transduction pathways. Organogenesis 4:68\u201375","journal-title":"Organogenesis"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1006\/bmme.1997.2583","volume":"61","author":"NT Kuo","year":"1997","unstructured":"Kuo NT, Norman JT, Wilson PD (1997) Acidic FGF regulation of hyperproliferation of fibroblasts in human autosomal dominant polycystic kidney disease. Biochem Mol Med 61:178\u2013191","journal-title":"Biochem Mol Med"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu VS, Taduri G, O\u2019Connell J, Teng Y, Cooke VG et al (2013) Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19:1047\u20131053","journal-title":"Nat Med"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1681\/ASN.2015030287","volume":"27","author":"WN Leonhard","year":"2016","unstructured":"Leonhard WN, Kunnen SJ, Plugge AJ, Pasternack A, Jianu SB et al (2016) Inhibition of activin signaling slows progression of polycystic kidney disease. J Am Soc Nephrol 27:3589\u20133599","journal-title":"J Am Soc Nephrol"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/ki.2008.500","volume":"74","author":"L Li","year":"2008","unstructured":"Li L, Huang L, Sung SS, Vergis AL, Rosin DL et al (2008a) The chemokine receptors CCR47 and CX3CR47 mediate monocyte\/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 74:1526\u20131537","journal-title":"Kidney Int"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nm1783","volume":"14","author":"X Li","year":"2008","unstructured":"Li X, Magenheimer BS, Xia S, Johnson T, Wallace DP et al (2008b) A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat Med 14:863\u2013868","journal-title":"Nat Med"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.4049\/jimmunol.0901473","volume":"183","author":"SL Lin","year":"2009","unstructured":"Lin SL, Castano AP, Nowlin BT, Lupher ML Jr, Duffield JS (2009) Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 183:6733\u20136743","journal-title":"J Immunol"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1681\/ASN.2012050486","volume":"25","author":"D Liu","year":"2014","unstructured":"Liu D, Wang CJ, Judge DP, Halushka MK, Ni J et al (2014) A Pkd1-Fbn1 genetic interaction implicates TGF-beta signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 25:81\u201391","journal-title":"J Am Soc Nephrol"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.devcel.2005.12.005","volume":"10","author":"SH Low","year":"2006","unstructured":"Low SH, Vasanth S, Larson CH, Mukherjee S, Sharma N et al (2006) Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev Cell 10:57\u201369","journal-title":"Dev Cell"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1242\/dmm.003194","volume":"3","author":"S Mangos","year":"2010","unstructured":"Mangos S, Lam PY, Zhao A, Liu Y, Mudumana S et al (2010) The ADPKD genes pkd1a\/b and pkd2 regulate extracellular matrix formation. Dis Model Mech 3:354\u2013365","journal-title":"Dis Model Mech"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/prca.200800163","volume":"3","author":"SB Mason","year":"2009","unstructured":"Mason SB, Lai X, Bacallao RL, Blazer-Yost BL, Gattone VH et al (2009) The biomarker enriched proteome of autosomal dominant polycystic kidney disease cyst fluid. Proteomics Clin Appl 3:1247\u20131250","journal-title":"Proteomics Clin Appl"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1369\/jhc.5A6866.2006","volume":"54","author":"SR McGlashan","year":"2006","unstructured":"McGlashan SR, Jensen CG, Poole CA (2006) Localization of extracellular matrix receptors on the chondrocyte primary cilium. J Histochem Cytochem 54:1005\u20131014","journal-title":"J Histochem Cytochem"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/01.ASN.0000109782.28991.26","volume":"15","author":"EA McPherson","year":"2004","unstructured":"McPherson EA, Luo Z, Brown RA, LeBard LS, Corless CC et al (2004) Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease. J Am Soc Nephrol 15:493\u2013500","journal-title":"J Am Soc Nephrol"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"F1284","DOI":"10.1152\/ajprenal.00428.2015","volume":"310","author":"MC Ming Wu","year":"2016","unstructured":"Ming Wu MC, Jing Ying, Junhui Gu, Mei Shuqin (2016) The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1. Am J Physiol Renal Physiol 310:F1284\u2013F1294","journal-title":"Am J Physiol Renal Physiol"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.ki.5002627","volume":"73","author":"M Mrug","year":"2008","unstructured":"Mrug M, Zhou J, Woo Y, Cui X, Szalai AJ et al (2008) Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int 73:63\u201376","journal-title":"Kidney Int"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/joim.12307","volume":"276","author":"M Mrug","year":"2014","unstructured":"Mrug M, Zhou J, Mrug S, Guay-Woodford LM, Yoder BK, Szalai AJ (2014) Complement C3 activation in cyst fluid and urine from autosomal dominant polycystic kidney disease patients. J Intern Med 276:539\u2013540","journal-title":"J Intern Med"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-981-10-2041-4_4","volume":"933","author":"H Mun","year":"2016","unstructured":"Mun H, Park JH (2016) Inflammation and Fibrosis in ADPKD. Adv Exp Med Biol 933:35\u201344","journal-title":"Adv Exp Med Biol"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000013552","volume":"20","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Ushiyama C, Suzuki S, Ebihara I, Shimada N et al (2000) Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease. Am J Nephrol 20:32\u201336","journal-title":"Am J Nephrol"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"17892","DOI":"10.1073\/pnas.0906070106","volume":"106","author":"M Niedermeier","year":"2009","unstructured":"Niedermeier M, Reich B, Rodriguez Gomez M, Denzel A, Schmidbauer K et al (2009) CD4\u2009+\u2009T cells control the differentiation of Gr1\u2009+\u2009monocytes into fibrocytes. Proc Natl Acad Sci U S A 106:17892\u201317897","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1172\/JCI22850","volume":"115","author":"S Nishio","year":"2005","unstructured":"Nishio S, Hatano M, Nagata M, Horie S, Koike T et al (2005) Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J Clin Invest 115:910\u2013918","journal-title":"J Clin Invest"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.bbadis.2011.06.012","volume":"1812","author":"J Norman","year":"2011","unstructured":"Norman J (2011) Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim Biophys Acta 1812:1327\u20131336","journal-title":"Biochim Biophys Acta"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL (1999) Activators and target genes of Rel\/NF-kB transcription factors. Oncogene 18:6853\u20136866","journal-title":"Oncogene"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000315859","volume":"32","author":"EY Park","year":"2010","unstructured":"Park EY, Seo MJ, Park JH (2010) Effects of specific genes activating RAGE on polycystic kidney disease. Am J Nephrol 32:169\u2013178","journal-title":"Am J Nephrol"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2005.09.005","volume":"38","author":"W Qi","year":"2006","unstructured":"Qi W, Chen X, Poronnik P, Pollock CA (2006) The renal cortical fibroblast in renal tubulointerstitial fibrosis. Int J Biochem Cell Biol 38:1\u20135","journal-title":"Int J Biochem Cell Biol"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"16981","DOI":"10.1073\/pnas.252484899","volume":"99","author":"F Qian","year":"2002","unstructured":"Qian F, Boletta A, Bhunia AK, Xu H, Liu L et al (2002) Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc Nat Acad Sci U S A 99:16981\u201316986","journal-title":"Proc Nat Acad Sci U S A"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1681\/ASN.2011030277","volume":"23","author":"S Qin","year":"2012","unstructured":"Qin S, Taglienti M, Cai L, Zhou J, Kreidberg JA (2012) c-Met and NF-kappaB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease. J Am Soc Nephrol 23:1309\u20131318","journal-title":"J Am Soc Nephrol"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1681\/ASN.2016111235","volume":"28","author":"A Raman","year":"2017","unstructured":"Raman A, Reif GA, Dai Y, Khanna A, Li X et al (2017) Integrin-linked kinase signaling promotes cyst growth and fibrosis in polycystic kidney disease. J Am Soc Nephrol 28:2708\u20132719","journal-title":"J Am Soc Nephrol"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ki.1996.383","volume":"50","author":"CA Rankin","year":"1996","unstructured":"Rankin CA, Suzuki K, Itoh Y, Ziemer DM, Grantham JJ et al (1996) Matrix metalloproteinases and TIMPS in cultured C57BL\/6\u00a0J-cpk kidney tubules. Kidney Int 50:835\u2013844","journal-title":"Kidney Int"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1242\/jcs.00963","volume":"117","author":"Jason S Rawlings","year":"2004","unstructured":"Rawlings Jason S, Rosler KM et al (2004) The JAK\/STAT signaling pathway. J Cell Sci 117:1281\u20131283","journal-title":"J Cell Sci"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785\u2013797","journal-title":"Nat Immunol"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ki.1996.10","volume":"49","author":"L Schaefer","year":"1996","unstructured":"Schaefer L, Han X, Gretz N, Hafner C, Meier K et al (1996) Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han: SPRD rat. Kidney Int 49:75\u201381","journal-title":"Kidney Int"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1093\/ndt\/gfl071","volume":"21","author":"G Schieren","year":"2006","unstructured":"Schieren G, Rumberger B, Klein M, Kreutz C, Wilpert J et al (2006) Gene profiling of polycystic kidneys. Nephrol Dial Transplant 21:1816\u20131824","journal-title":"Nephrol Dial Transplant"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.1219179","volume":"336","author":"C Schulz","year":"2012","unstructured":"Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N et al (2012) A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336:86\u201390","journal-title":"Science"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/labinvest.2010.45","volume":"90","author":"P Semedo","year":"2010","unstructured":"Semedo P, Donizetti-Oliveira C, Burgos-Silva M, Cenedeze MA, Avancini Costa Malheiros DM et al (2010) Bone marrow mononuclear cells attenuate fibrosis development after severe acute kidney injury. Lab Invest 90:685\u2013695","journal-title":"Lab Invest"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122:787\u2013795","journal-title":"J Clin Invest"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.1190594","volume":"330","author":"RJ Snelgrove","year":"2010","unstructured":"Snelgrove RJ, Jackson PL, Hardison MT, Noerager BD, Kinloch A et al (2010) A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science 330:90\u201394","journal-title":"Science"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","volume":"18","author":"X Song","year":"2009","unstructured":"Song X, Di Giovanni V, He N, Wang K, Ingram A et al (2009) Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 18:2328\u20132343","journal-title":"Hum Mol Genet"},{"key":"5_CR79","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-3-319-51436-9_12","volume":"60","author":"CJ Song","year":"2017","unstructured":"Song CJ, Zimmerman KA, Henke SJ, Yoder BK (2017) Inflammation and fibrosis in polycystic kidney disease. Results Probl Cell Differ 60:323\u2013344","journal-title":"Results Probl Cell Differ"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/372679a0","volume":"372","author":"K Stark","year":"1994","unstructured":"Stark K, Vainio S, Vassileva G, McMahon AP (1994) Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372:679\u2013683","journal-title":"Nature"},{"key":"5_CR81","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/joim.12214","volume":"276","author":"Z Su","year":"2014","unstructured":"Su Z, Wang X, Gao X, Liu Y, Pan C et al (2014) Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J Int Med 276:470\u2013485","journal-title":"J Int Med"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"F596","DOI":"10.1152\/ajprenal.00365.2015","volume":"310","author":"A Sureshbabu","year":"2016","unstructured":"Sureshbabu A, Muhsin SA, Choi ME (2016) TGF-beta signaling in the kidney: profibrotic and protective effects. Am J Physiol Renal Physiol 310:F596\u2013F606","journal-title":"Am J Physiol Renal Physiol"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ki.2012.446","volume":"83","author":"KI Swenson-Fields","year":"2013","unstructured":"Swenson-Fields KI, Vivian CJ, Salah SM, Peda JD, Davis BM et al (2013) Macrophages promote polycystic kidney disease progression. Kidney Int 83:855\u2013864","journal-title":"Kidney Int"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.1073\/pnas.1103816108","volume":"108","author":"JJ Talbot","year":"2011","unstructured":"Talbot JJ, Shillingford JM, Vasanth S, Doerr N, Mukherjee S et al (2011) Polycystin-1 regulates STAT activity by a dual mechanism. Proc Nati Acad Sci U S A 108:7985\u20137990","journal-title":"Proc Nati Acad Sci U S A"},{"key":"5_CR85","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.semnephrol.2010.03.004","volume":"30","author":"MA Vernon","year":"2010","unstructured":"Vernon MA, Mylonas KJ, Hughes J (2010) Macrophages and renal fibrosis. Semin Nephrol 30:302\u2013317","journal-title":"Semin Nephrol"},{"key":"5_CR86","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrneph.2009.76","volume":"5","author":"E Vilayur","year":"2009","unstructured":"Vilayur E, Harris DC (2009) Emerging therapies for chronic kidney disease: what is their role? Nat Rev Nephrol 5:375\u2013383","journal-title":"Nat Rev Nephrol"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10157-010-0372-2","volume":"15","author":"T Wada","year":"2011","unstructured":"Wada T, Sakai N, Sakai Y, Matsushima K, Kaneko S, Furuichi K (2011) Involvement of bone-marrow-derived cells in kidney fibrosis. Clin Exp Nephrol 15:8\u201313","journal-title":"Clin Exp Nephrol"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/ki.2013.488","volume":"85","author":"DP Wallace","year":"2014","unstructured":"Wallace DP, White C, Savinkova L, Nivens E, Reif GA et al (2014) Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease. Kidney Int 85:845\u2013854","journal-title":"Kidney Int"},{"key":"5_CR89","doi-asserted-by":"publisher","first-page":"21729","DOI":"10.1074\/jbc.M703218200","volume":"282","author":"W Wei","year":"2007","unstructured":"Wei W, Hackmann K, Xu H, Germino G, Qian F (2007) Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene. J Biol Chem 282:21729\u201321737","journal-title":"J Biol Chem"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"e23650","DOI":"10.4161\/jkst.23650","volume":"2","author":"T Weimbs","year":"2013","unstructured":"Weimbs T, Olsan EE, Talbot JJ (2013) Regulation of STATs by polycystin-1 and their role in polycystic kidney disease. Jak-Stat 2:e23650","journal-title":"Jak-Stat"},{"key":"5_CR91","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000020592","volume":"7","author":"PD Wilson","year":"1999","unstructured":"Wilson PD, Burrow CR (1999) Cystic diseases of the kidney: role of adhesion molecules in normal and abnormal tubulogenesis. Exp Nephrol 7:114\u2013124","journal-title":"Exp Nephrol"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/jcp.1041500220","volume":"150","author":"PD Wilson","year":"1992","unstructured":"Wilson PD, Hreniuk D, Gabow PA (1992) Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia. J Cell Physiol 150:360\u2013369","journal-title":"J Cell Physiol"},{"key":"5_CR93","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000425085","volume":"118","author":"PD Wilson","year":"1996","unstructured":"Wilson PD, Norman JT, Kuo NT, Burrow CR (1996) Abnormalities in extracellular matrix regulation in autosomal dominant polycystic kidney disease. Contrib Nephrol 118:126\u2013134","journal-title":"Contrib Nephrol"},{"key":"5_CR94","first-page":"1311","volume":"79","author":"PD Wilson","year":"1999","unstructured":"Wilson PD, Geng L, Li X, Burrow CR (1999) The PKD1 gene product, \u201cpolycystin-1,\u201d is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia. Lab Invest 79:1311\u20131323","journal-title":"Lab Invest"},{"key":"5_CR95","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMe1211857","volume":"367","author":"RP Wuthrich","year":"2012","unstructured":"Wuthrich RP, Mei C (2012) Aquaretic treatment in polycystic kidney disease. N Engl J Med 367:2440\u20132442","journal-title":"N Engl J Med"},{"key":"5_CR96","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000449030","volume":"2","author":"C Xue","year":"2016","unstructured":"Xue C, Zhou CC, Wu M, Mei CL (2016) The clinical manifestation and management of autosomal dominant polycystic kidney disease in China. Kidney Dis (Basel) 2:111\u2013119","journal-title":"Kidney Dis (Basel)"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.kint.2017.10.027","volume":"93","author":"C Xue","year":"2018","unstructured":"Xue C, Zhou C, Mei C (2018) Total kidney volume: the most valuable predictor of autosomal dominant polycystic kidney disease progression. Kidney Int 93:540\u2013542","journal-title":"Kidney Int"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/01.ASN.0000103225.68136.E6","volume":"15","author":"S Yamashita","year":"2004","unstructured":"Yamashita S, Maeshima A, Kojima I, Nojima Y (2004) Activin A is a potent activator of renal interstitial fibroblasts. J Am Soc Nephrol 15:91\u2013101","journal-title":"J Am Soc Nephrol"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1681\/ASN.2018010074","volume":"29","author":"Y Yang","year":"2018","unstructured":"Yang Y, Chen M, Zhou J, Lv J, Song S et al (2018) Interactions between macrophages and cyst-lining epithelial cells promote kidney cyst growth in Pkd1-deficient mice. J Am Soc Nephrol 29:2310\u20132325","journal-title":"J Am Soc Nephrol"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/ki.1992.413","volume":"42","author":"M Zeier","year":"1992","unstructured":"Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E (1992) Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int 42:1259\u20131265","journal-title":"Kidney Int"},{"key":"5_CR101","doi-asserted-by":"publisher","first-page":"c169","DOI":"10.1159\/000116887","volume":"108","author":"R Zeltner","year":"2008","unstructured":"Zeltner R, Hilgers KF, Schmieder RE, Porst M, Schulze BD et al (2008) A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease. Nephron Clin Pract 108:c169\u2013c175","journal-title":"Nephron Clin Pract"},{"key":"5_CR102","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","volume":"14","author":"D Zheng","year":"2003","unstructured":"Zheng D, Wolfe M, Cowley BD Jr, Wallace DP et al (2003) Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 14:2588\u20132595","journal-title":"J Am Soc Nephrol"},{"issue":"692\u2013692","key":"5_CR103","first-page":"e691","volume":"161","author":"K Zimmerman","year":"2015","unstructured":"Zimmerman K, Yoder BK (2015) SnapShot: sensing and signaling by cilia. Cell 161(692\u2013692):e691","journal-title":"Cell"}],"container-title":["Advances in Experimental Medicine and Biology","Renal Fibrosis: Mechanisms and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-8871-2_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T07:00:38Z","timestamp":1664089238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-8871-2_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811388705","9789811388712"],"references-count":103,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-8871-2_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"9 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}